Bicyclol is a compound under clinical investigation for its potential role in addressing acute drug-induced liver injury. It is an active pharmaceutical ingredient with a molecular structure characterized by multiple aromatic rings and ether groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 118159-48-1
Bifendate
pharmaceutical raw material
Lafutidine
pharmaceutical raw material
Tazarotene
pharmaceutical raw material
5-Chloro-1-{1-oxo-1-[3-(2-oxo-2,3,3a,7a-tetrahydro-1H-benzimidazol-1-yl)propyl]-1λ⁵-piperidin-4-yl}-1,3,3a,7a-tetrahydro-2H-benzimidazol-2-one
pharmaceutical raw material
N-[4-(4-Fluorophenyl)-5-formyl-6-(1-methylethyl)-2-pyrimidinyl]-N-methylmethanesulfonamide
pharmaceutical raw material
7,7'-Dimethoxy-2H,2'H-[4,4'-bi-1,3-benzodioxole]-5,5'-dicarboxylic acid
pharmaceutical intermediate
methyl 4-[5-(hydroxymethyl)-7-methoxy-1,3-benzodioxol-4-yl]-7-methoxy-1,3-benzodioxole-5-carboxylate
KXMTXZACPVCDMH-UHFFFAOYSA-N
COC1=C2C(=C(C(=C1)CO)C3=C4C(=C(C=C3C(=O)OC)OC)OCO4)OCO2